TABLEĀ 3

Therapeutic ratios of validated screening hits

DrugUAMS-1USA300Small-colony variants
Daunorubicin<0.125<0.125<0.25
Ketoconazole0.50.51
Rifapentine2,0001,0001,000
Sitafloxacin8,0001,0244,000